Pharmaceuticals Industry Deals and Trends in November 2021 – Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
The pharmaceutical and healthcare market reported 503 deals worth $47.5 billion in November 2021. The market registered an increase in the number of mergers and acquisitions (M&As) including asset purchases. Capital raising, through equity and debt offerings, reported an increase in the number of deals and a decrease in deal values.
The Pharmaceuticals Industry Deals and Trends report provides data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As), and financings in the pharmaceutical industry. The report portrays detailed comparative data on the number of deals and their value in the last six months subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceutical industry.
Pharmaceuticals Market Segmentation by Regions
The key regions in the pharmaceuticals and healthcare market are North America, Europe, Asia Pacific, and the rest of the world. North America reported a decrease in the number of deals and deal value in November 2021.
Pharmaceuticals Market Segmentation by Deal Types
The key deal types in the pharmaceuticals and healthcare market are PE/VC, partnerships, M&A, licensing agreements, and capital raising (equity/debt offerings). PE/VC segment recorded the highest number of deals, followed by the capital raisings (equity and debt offerings) segment.
Pharmaceuticals and Healthcare Market Analysis, by Deal Types
For more deal type insights into the pharmaceuticals and healthcare market, download a free report sample
Pharmaceuticals Market Segmentation by Therapy Areas
The key therapy areas in the pharmaceuticals and healthcare market are oncology, central nervous system, infectious disease, immunology, metabolic disorders, gastrointestinal, and cardiovascular. The oncology therapeutics market recorded the majority of M&A deals, followed by the central nervous system therapeutics market.
Pharmaceuticals and Healthcare Market Analysis, by Therapy Areas
For more therapy area insights into the pharmaceuticals and healthcare market, download a free report sample
Pharmaceuticals Market - Competitive Landscape
The leading financial advisors in the pharmaceuticals and healthcare market are The Goldman Sachs Group Inc, Centerview Partners LLC, Jefferies LLC, Rothschild & Co SCA, and SVB Financial Group. The Goldman Sachs Group Inc topped the M&A financial advisory league.
Pharmaceuticals and Healthcare Market Analysis, by Financial Advisors
To know more about the financial advisors in the pharmaceuticals and healthcare market, download a free report sample
Pharmaceuticals Market Report Overview
| Number of Deals | 503 |
| Total Worth (2021) | $47.5 billion |
| Key Regions | North America, Europe, Asia Pacific, and the Rest of the World |
| Key Deal Types | PE/VC, Partnerships, M&A, Licensing Agreements, and Capital Raising (Equity/Debt Offerings) |
| Key Therapy Areas | Oncology, Central Nervous System, Infectious Disease, Immunology, Metabolic Disorders, Gastrointestinal, and Cardiovascular |
| Leading Financial Advisors | The Goldman Sachs Group Inc, Centerview Partners LLC, Jefferies LLC, Rothschild & Co SCA, and SVB Financial Group |
Scope
This report provides:
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Reviews of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito-urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women’s health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas that are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on the clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happening in the pharmaceutical industry.
- Geographies including North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings.
Reasons to Buy
- Enhance your decision-making capability in a more rapid and time-sensitive manner
- Find out the major deal-performing segments for investments in your industry
- Evaluate the types of companies which are entering into partnership or licensing agreements, divesting and acquiring assets
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving a majority of the upfront and milestone payments in the pharmaceutical industry
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies
- Evaluate the clinical development stages where a majority of the partnerships and licensing agreements are happening
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry
- Identify growth segments and opportunities in each region within the industry
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry
Table of Contents
List of Tables
List of Figures
Frequently Asked Questions
The pharmaceuticals and healthcare market reported 503 deals in November 2021.
The pharmaceuticals and healthcare market reported deals worth $47.5 billion in November 2021.
The key regions in the pharmaceuticals and healthcare market are North America, Europe, Asia Pacific, and the rest of the world.
The key deal types in the pharmaceuticals and healthcare market are PE/VC, partnerships, M&A, licensing agreements, and capital raising (equity/debt offerings).
The key therapy areas in the pharmaceuticals and healthcare market are oncology, central nervous system, infectious disease, immunology, metabolic disorders, gastrointestinal, and cardiovascular.
The leading financial advisors in the pharmaceuticals and healthcare market are The Goldman Sachs Group Inc, Centerview Partners LLC, Jefferies LLC, Rothschild & Co SCA, and SVB Financial Group.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Still undecided about purchasing this report?
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.